Which hedge funds own NVAX? NOVAVAX INC, Q2 2026 13F holders
Healthcare · Open on the interactive board
11 of the hedge funds tracked by WhaleCreep disclosed a position in NVAX (NOVAVAX INC) in their Q2 2026 13F filings, worth $170.3m in total. The largest holder by portfolio weight is Sculptor Capital Management at 0.2% of its book. 1 exited: Farallon Capital Management.
11tracked managers holding
0opened this quarter
1exited this quarter
Which hedge funds hold NVAX? Current holders by portfolio weight
| Manager | As of | Weight of book | Value | Shares | Δ shares | Action |
|---|---|---|---|---|---|---|
| Sculptor Capital Management | Q2 2026 | 0.2% | $24.1m | 20,252,000 | 0% | held |
| Coatue Management | Q2 2026 | 0.1% | $36.1m | 3,836,986 | 0% | held |
| D. E. Shaw & Co | Q2 2026 | 0.0% | $53.2m | 5,650,905 | -27% | reduced |
| Millennium Management | Q2 2026 | 0.0% | $16.7m | 1,768,163 | -54% | reduced |
| Point72 Asset Management LP | Q2 2026 | 0.0% | $6.3m | 664,286 | -56% | reduced |
| Brevan Howard Capital Management | Q2 2026 | 0.0% | $657.7k | 69,815 | 33% | added |
| Citadel Advisors | Q2 2026 | 0.0% | $16.0m | 1,695,313 | 51% | added |
| Point72 Asset Management LP | Q2 2026 | 0.0% | $5.2m | 4,400,000 | 0% | held |
| Renaissance Technologies LLC | Q2 2026 | 0.0% | $4.7m | 501,783 | 1% | added |
| Marshall Wace | Q2 2026 | 0.0% | $6.1m | 652,773 | -44% | reduced |
| Tudor Investment | Q2 2026 | 0.0% | $1.2m | 125,468 | -3% | reduced |
Exited since the previous quarter
| Manager | Prior weight | Prior value |
|---|---|---|
| Farallon Capital Management | 0.0% | $179.1k |
How has hedge fund ownership of NVAX changed?
| Quarter | Managers holding | Combined value |
|---|---|---|
| Q2 2026 | 10 | $170.3m |
| Q1 2026 | 11 | $189.3m |
| Q4 2025 | 2 | $6.2m |
| Q3 2025 | 4 | $56.4m |
| Q2 2025 | 4 | $38.5m |
| Q1 2025 | 4 | $37.4m |
| Q4 2024 | 3 | $21.5m |
| Q3 2024 | 5 | $68.0m |
| Q2 2024 | 4 | $64.5m |
| Q1 2024 | 4 | $21.0m |
| Q4 2023 | 1 | $7.3m |
| Q2 2023 | 4 | $11.1m |
| Q1 2023 | 3 | $36.8m |
| Q4 2022 | 5 | $62.4m |
| Q3 2022 | 5 | $64.9m |
| Q2 2022 | 7 | $126.8m |
Counts every tracked manager that disclosed NVAX in that quarter's filing, including managers that have since stopped filing.